440 related articles for article (PubMed ID: 26022911)
1. Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.
Selvin E; Rawlings AM; Lutsey PL; Maruthur N; Pankow JS; Steffes M; Coresh J
Circulation; 2015 Jul; 132(4):269-77. PubMed ID: 26022911
[TBL] [Abstract][Full Text] [Related]
2. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.
Jung M; Warren B; Grams M; Kwong YD; Shafi T; Coresh J; Rebholz CM; Selvin E
J Diabetes; 2018 Apr; 10(4):276-285. PubMed ID: 29055090
[TBL] [Abstract][Full Text] [Related]
3. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.
Selvin E; Rawlings AM; Grams M; Klein R; Sharrett AR; Steffes M; Coresh J
Lancet Diabetes Endocrinol; 2014 Apr; 2(4):279-288. PubMed ID: 24703046
[TBL] [Abstract][Full Text] [Related]
4. Glycaemic markers and all-cause mortality in older adults with and without diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
Rooney MR; Tang O; Pankow JS; Selvin E
Diabetologia; 2021 Feb; 64(2):339-348. PubMed ID: 32990802
[TBL] [Abstract][Full Text] [Related]
5. Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
Ding N; Kwak L; Ballew SH; Jaar B; Hoogeveen RC; Ballantyne CM; Sharrett AR; Folsom AR; Heiss G; Salameh M; Coresh J; Hirsch AT; Selvin E; Matsushita K
Atherosclerosis; 2018 Jul; 274():86-93. PubMed ID: 29753232
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results From the Atherosclerosis Risk in Communities Study.
Loomis SJ; Li M; Maruthur NM; Baldridge AS; North KE; Mei H; Morrison A; Carson AP; Pankow JS; Boerwinkle E; Scharpf R; Rasmussen-Torvik LJ; Coresh J; Duggal P; Köttgen A; Selvin E
Diabetes; 2018 Aug; 67(8):1684-1696. PubMed ID: 29844224
[TBL] [Abstract][Full Text] [Related]
7. Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study.
Parrinello CM; Matsushita K; Woodward M; Wagenknecht LE; Coresh J; Selvin E
Diabetes Obes Metab; 2016 Sep; 18(9):899-906. PubMed ID: 27161077
[TBL] [Abstract][Full Text] [Related]
8. Association between glycated albumin, fructosamine, and HbA1c with neonatal outcomes in a prospective cohort of women with gestational diabetes mellitus.
Mendes N; Alves M; Andrade R; Ribeiro RT; Papoila AL; Serrano F
Int J Gynaecol Obstet; 2019 Sep; 146(3):326-332. PubMed ID: 31242319
[TBL] [Abstract][Full Text] [Related]
9. Alternative markers of hyperglycemia and risk of diabetes.
Juraschek SP; Steffes MW; Miller ER; Selvin E
Diabetes Care; 2012 Nov; 35(11):2265-70. PubMed ID: 22875225
[TBL] [Abstract][Full Text] [Related]
10. Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.
Parrinello CM; Selvin E
Curr Diab Rep; 2014; 14(11):548. PubMed ID: 25249070
[TBL] [Abstract][Full Text] [Related]
11. Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol.
Selvin E; Warren B; He X; Sacks DB; Saenger AK
Clin Chem; 2018 May; 64(5):843-850. PubMed ID: 29436378
[TBL] [Abstract][Full Text] [Related]
12. Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients.
Shafi T; Sozio SM; Plantinga LC; Jaar BG; Kim ET; Parekh RS; Steffes MW; Powe NR; Coresh J; Selvin E
Diabetes Care; 2013 Jun; 36(6):1522-33. PubMed ID: 23250799
[TBL] [Abstract][Full Text] [Related]
13. Association between glycated haemoglobin, glycated albumin and fructosamine with neonatal birthweight and large-for-date status infants in gestational diabetes mellitus: a prospective cohort study.
Mendes N; Alves M; Andrade R; Ribeiro RT; Papoila AL; Serrano F
J Obstet Gynaecol; 2019 Aug; 39(6):768-773. PubMed ID: 31007102
[TBL] [Abstract][Full Text] [Related]
14. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
[TBL] [Abstract][Full Text] [Related]
15. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
[TBL] [Abstract][Full Text] [Related]
16. The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study.
George C; Matsha TE; Korf M; Zemlin AE; Erasmus RT; Kengne AP
BMC Nephrol; 2020 Jan; 21(1):32. PubMed ID: 32000712
[TBL] [Abstract][Full Text] [Related]
17. Nontraditional markers of glycemia: associations with microvascular conditions.
Selvin E; Francis LM; Ballantyne CM; Hoogeveen RC; Coresh J; Brancati FL; Steffes MW
Diabetes Care; 2011 Apr; 34(4):960-7. PubMed ID: 21335368
[TBL] [Abstract][Full Text] [Related]
18. Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.
Juraschek SP; Steffes MW; Selvin E
Clin Chem; 2012 Dec; 58(12):1648-55. PubMed ID: 23019309
[TBL] [Abstract][Full Text] [Related]
19. Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.
Parrinello CM; Sharrett AR; Maruthur NM; Bergenstal RM; Grams ME; Coresh J; Selvin E
Diabetes Care; 2016 Apr; 39(4):589-95. PubMed ID: 26681712
[TBL] [Abstract][Full Text] [Related]
20. HbA1c, Fructosamine, and Glycated Albumin in the Detection of Dysglycaemic Conditions.
Ribeiro RT; Macedo MP; Raposo JF
Curr Diabetes Rev; 2016; 12(1):14-9. PubMed ID: 26126638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
